MAVS Cys508 palmitoylation promotes its aggregation on the mitochondrial outer membrane and antiviral innate immunity
Proceedings of the National Academy of Sciences · 20.08.2024 · 121 (34)
DOI: 10.1073/pnas.2403392121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.08.2024. Verfasst von Yinong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853. Hauptthemen laut MEDLINE: Lipoylation, Adaptor Proteins, Signal Transducing, Immunity, Innate, Mitochondrial Membranes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCRR NIH HHS, HHS | NIH (NIH).
Abstract (Originalsprache)
Cysteine palmitoylation or S -palmitoylation catalyzed by the ZDHHC family of acyltransferases regulates the biological function of numerous mammalian proteins as well as viral proteins. However, understanding of the role of S -palmitoylation in antiviral immunity against RNA viruses remains very limited. The adaptor protein MAVS forms functionally essential prion-like aggregates upon activation by viral RNA-sensing RIG-I-like receptors. Here, we identify that MAVS, a C-terminal tail-anchored mitochondrial outer membrane protein, is S -palmitoylated by ZDHHC7 at Cys508, a residue adjacent to the tail-anchor transmembrane helix. Using superresolution microscopy and other biochemical techniques, we found that the mitochondrial localization of MAVS at resting state mainly depends on its transmembrane tail-anchor, without regulation by Cys508 S -palmitoylation. However, upon viral infection, MAVS S -palmitoylation stabilizes its aggregation on the mitochondrial outer membrane and thus promotes subsequent propagation of antiviral signaling. We further show that inhibition of MAVS S -palmitoylation increases the host susceptibility to RNA virus infection, highlighting the importance of S -palmitoylation in the antiviral innate immunity. Also, our results indicate ZDHHC7 as a potential therapeutic target for MAVS-related autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853.
- Department of Molecular Medicine, Cornell University, Ithaca, NY 14853.
- Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853.
ORCID-Profile: Yinong Liu, Dan Hou, Wenzhe Chen, Garrison P Komaniecki, Tao Yu, Maurine E Linder, Hening Lin
Förderung
- NIAID NIH HHS
- NCRR NIH HHS
- HHS | NIH (NIH)
- HHMI (HHMI)
Zitieren
APA
Liu, Y., Hou, D., Chen, W., Lu, X., Komaniecki, G. P., Xu, Y., Yu, T., Zhang, S. M., Linder, M. E., & Lin, H. (2024). MAVS Cys508 palmitoylation promotes its aggregation on the mitochondrial outer membrane and antiviral innate immunity. Proceedings of the National Academy of Sciences, 121(34). https://doi.org/10.1073/pnas.2403392121
Vancouver
Liu Y, Hou D, Chen W, Lu X, Komaniecki GP, Xu Y, et al. MAVS Cys508 palmitoylation promotes its aggregation on the mitochondrial outer membrane and antiviral innate immunity. Proceedings of the National Academy of Sciences. 2024;121(34). doi:10.1073/pnas.2403392121
BibTeX
@article{Liu2024,
author = {Liu, Yinong and Hou, Dan and Chen, Wenzhe and Lu, Xuan and Komaniecki, Garrison P and Xu, Yilai and Yu, Tao and Zhang, Sophia M and Linder, Maurine E and Lin, Hening},
title = {MAVS Cys508 palmitoylation promotes its aggregation on the mitochondrial outer membrane and antiviral innate immunity},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {34},
doi = {10.1073/pnas.2403392121}
}
EUVIMED